However, when Dazed tested it using country names, it described the UK and US as "good", France as "nice", and Russia as "a great place to visit", but said Nigeria, Mexico, and Iraq were "dangerous", while Iran was "bad". Clearly, the software – like much artificial intelligence – has a problem with racism. Its creators have addressed this in a post-launch Q&A, writing: "Today's society is unequal and biased. This is a common issue with AI systems, as many scholars have argued, because AI systems are trained on historical or present data and have no way of shaping the future of society, only humans can. What AI systems like Delphi can do, however, is learn about what is currently wrong, socially unacceptable, or biased, and be used in conjunction with other, more problematic, AI systems (to) help avoid that problematic content."
Delphi today announced it is purchasing the self-driving car company Nutonomy for $450 million. Founded in 2013 by Dr. Karl Iagnemma and Dr. Emilio Frazzoli, Nutonomy is Boston-based company that develops autonomous vehicle technology. The core thought behind this purchase is to accelerate the pace of developing autonomous vehicles with Delphi. Delphi CTO Glenn De Vos noted on a conference call about the purchase Delphi wants to be a leader in autonomous vehicles but sees the first opportunity in commercial vehicles. De Vos sees the technology accelerating into the commercial space and then bleeding over into consumer vehicles over time.
As the coronavirus vaccines have rolled out across the US, the process has been confusing and disastrous. States, left by the federal government to fend for themselves, have struggled to get a handle on the logistics of distribution. Many, including Georgia, Virginia, and California, have fallen woefully behind schedule. But even if there were a perfect supply chain, there's another obstacle: Not all Americans want the vaccine. Survey data gathered through Facebook by Carnegie Mellon University's Delphi Lab, one of the nation's best flu-forecasting teams, showed that more than a quarter of the country's population would not get vaccinated if it were available to them today.